CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Revised Audited Financial Results For The Quarter And Year Ended 31.03.2020
Submission of Revised Audited Financial Results for the quarter and year ended 31.03.202006-08-2020
06-08-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholding for the Period Ended June 30, 2020
Chemo Pharma Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click here13-07-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate received from M/s. Purva Registry (India) Private Limited, Registrar and Share Transfer Agent (RTA) of our Company as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2020.08-07-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Managing Director / Whole Time Director08-07-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Closure of Trading Window
This is to inform you that as per the Company''s Code of Conduct to regulate, monitor and report trading by insiders (''Code''), the Trading Window for dealing in the securities of the Company will be closed for all the Designated Persons and their immediate relatives with effect from July 1, 2020 till 48 (forty eight) hours after the Un-Audited financial results of the Company for the quarter ended June 30, 2020 become generally available information. Kindly take the above information on your records. This information is also being hosted on the website of the Company.30-06-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Submission Of Audited Financial Results For The Quarter And Year Ended 31.03.2020
Submission of Audited Financial Results for the quarter and year ended 31.03.202026-06-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Outcome Of Board Meeting Held On 26.06.2020
Outcome of Board Meeting held on 26.06.202026-06-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - DISCLOSURE OF MATERIAL IMPACT OF COVID-19 PANDEMIC
Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, please find enclosed herewith disclosure on material impact of COVID-19 pandemic on the Company.23-06-2020
CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for To Consider And Approve The Audited Financial Results For The Quarter And Year Ended 31St March, 2020 And Approve Audited Financial Statements For The Year Ended 31St March, 2020 And Auditors Report Thereon Duly Reviewed By The Audit Committee.
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/06/2020 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Friday, 26th June, 2020 at 04:00 p.m. at the Corporate Office of the Company i.e. at Empire House, 3rd Floor, 214, Dr. D. N. Road, Fort, Mumbai - 400 001 to transact the following business: 1.To consider and approve the Audited Financial Results for the quarter and year ended 31st March, 2020. 2.To consider and approve Audited Financial Statements for the year ended 31st March, 2020 and Auditors Report thereon duly reviewed by the Audit Committee.16-06-2020